Description

REVOLAX Sub-Q with Lidocaine

REVOLAX Sub-Q is a professional cross-linked hyaluronic acid dermal filler with lidocaine. Supplied as one sterile 1.1ml prefilled syringe, it has the firmest gel profile in the REVOLAX range and is intended for qualified professional assessment of suitable deep facial-support and contouring applications.

The formulation contains 24mg/ml of cross-linked hyaluronic acid and 0.3% lidocaine. The incorporated lidocaine is intended to improve patient comfort during administration. REVOLAX Sub-Q is manufactured in South Korea by ACROSS Co., Ltd.

REVOLAX Sub-Q must only be purchased and administered by appropriately qualified, trained and insured healthcare or aesthetic professionals.

What Is REVOLAX Sub-Q Used For?

REVOLAX Sub-Q is positioned for professional deep-subcutaneous applications where a high-support gel profile may be appropriate. It has a firmer, more supportive profile than REVOLAX Fine and REVOLAX Deep.

Depending on the patient’s anatomy, tissue characteristics, vascular anatomy and individual treatment plan, a qualified practitioner may consider REVOLAX Sub-Q for selected deep facial folds, cheeks, chin, jawline, nose or facial-contour treatments. These examples are general product-positioning information only and are not treatment recommendations for every patient.

The treating professional must determine whether this product, the intended treatment area, placement depth, quantity and technique are appropriate following an individual consultation and risk assessment.

REVOLAX Sub-Q Product Specifications

• Product: REVOLAX Sub-Q with Lidocaine
• Product type: Cross-linked hyaluronic acid dermal filler
• Hyaluronic acid concentration: 24mg/ml
• Lidocaine concentration: 0.3% or 3mg/ml
• Formulation: Monophasic, cross-linked hyaluronic acid gel
• Presentation: One 1.1ml prefilled syringe
• Recommended professional positioning: Deep subcutaneous tissue
• Needles: Two 25G sterile needles, subject to supplied packaging
• Manufacturer: ACROSS Co., Ltd.
• Country of manufacture: South Korea
• Storage: 2°C to 25°C, protected from direct sunlight
• Use: Professional aesthetic use only

Always check the physical carton to confirm the exact syringe volume, supplied accessories, batch number, expiry date and current manufacturer instructions before treatment or publication.

Key Features of REVOLAX Sub-Q

• Professional cross-linked hyaluronic acid dermal filler
• Contains 24mg/ml hyaluronic acid
• Contains 0.3% lidocaine
• Firm, high-support gel profile
• Designed for suitable deep professional applications
• Supplied as a sterile 1.1ml prefilled syringe
• Part of the REVOLAX dermal filler range
• Manufactured by ACROSS in South Korea

Cross-Linked Hyaluronic Acid

Hyaluronic acid is naturally present within the human body and contributes to tissue hydration and structure. In a dermal filler, cross-linking creates a gel that can provide temporary physical support when correctly placed in suitable tissue by a qualified professional.

REVOLAX Sub-Q has a firmer and more supportive profile than REVOLAX Fine or REVOLAX Deep. It should be selected only where the practitioner considers a high-support filler appropriate for the anatomy, intended tissue depth and treatment objective.

Hyaluronic acid fillers are not permanent implants. Treatment response and visible duration can vary according to placement, quantity, treatment area, individual metabolism, lifestyle and tissue characteristics. No specific result or duration can be guaranteed.

REVOLAX Sub-Q Compared with Other REVOLAX Fillers

• REVOLAX Fine: Fine gel profile for suitable superficial-dermis applications.
• REVOLAX Deep: Medium gel profile for suitable mid-to-deep dermis and upper-subcutaneous applications.
• REVOLAX Sub-Q: Firm gel profile for suitable deep-volume and contouring applications.

The appropriate product should be selected according to individual anatomy, intended treatment area, tissue depth and required support—not simply according to the severity of a visible line.

Professional Consultation and Patient Assessment

Before using REVOLAX Sub-Q, the practitioner should review the patient’s medical history, allergies, medication, previous aesthetic procedures, skin condition and treatment expectations. The intended treatment area should be assessed for infection, inflammation, irritation, broken skin or another factor that could make treatment unsuitable.

Patients should receive clear information about the planned treatment, realistic limitations, possible adverse effects, aftercare and alternative options. Informed consent should be obtained before treatment. Product traceability details, including batch number and expiry date, should be documented in the patient record.

Important Safety Information

REVOLAX Sub-Q must never be injected into a blood vessel. Accidental intravascular administration of any dermal filler can cause serious complications, including vascular occlusion, tissue damage, skin necrosis, visual impairment, blindness or stroke.

Administration requires detailed facial-anatomy knowledge, aseptic technique and the ability to recognise and manage complications promptly. Qualified practitioners should maintain appropriate emergency procedures, equipment and referral arrangements.

Do not use REVOLAX Sub-Q in patients with known hypersensitivity to hyaluronic acid, lidocaine, amide-type local anaesthetics or another product component. Do not treat areas affected by active infection, inflammation, irritation, broken skin, untreated skin disease or an active cold-sore outbreak.

Pregnancy, breastfeeding, immune conditions, anticoagulant medication, bleeding disorders, significant allergies, recent treatment in the same area and a history of problematic scarring require careful professional consideration. Review the supplied manufacturer instructions before use.

Possible Treatment Reactions

Temporary injection-site reactions may include redness, swelling, tenderness, bruising, itching, firmness, discomfort or discolouration. Less common complications can be serious and may require urgent professional assessment.

Patients should receive written aftercare information and clear contact instructions. Unexpected or increasing pain, skin blanching, unusual colour changes, visual symptoms or neurological symptoms require immediate professional attention.

Storage, Handling and Traceability

Store REVOLAX Sub-Q at 2°C to 25°C and protect it from direct sunlight unless the supplied carton states otherwise. Do not use the product if its sterile packaging is damaged, the expiry date has passed, the gel appears abnormal or storage conditions cannot be verified.

The prefilled syringe and supplied needles are single-use devices. Do not reuse or resterilise them. Dispose of used equipment and unused product through appropriate clinical and sharps-waste procedures.

Order REVOLAX Sub-Q

REVOLAX Sub-Q with Lidocaine is available from The Clinic Vault for eligible professional purchasers. Customers are responsible for ensuring that they have the qualifications, training, insurance and legal authority required to purchase and administer injectable aesthetic products.

Explore our professional aesthetic product collection or review the REVOLAX product specifications before procurement.

Professional-use notice: This page provides product-identification and professional-procurement information only. It does not replace supplied manufacturer instructions, accredited clinical training, local regulations, professional judgement or an individual patient assessment.